Hazmatters - The Dangerously Good Hazmat Podcast
|December 15, 2020 // Season 01 Episode 07 // #COVID-19-vaccine-transport, #dry-ice-packaging, #UN1845, #liquid-nitrogen-transport, #UN1977|
The Dangerous Goods Implications of Shipping COVID-19 Vaccines (Part 2 of 2)
Because COVID-19 vaccine doses need to be transported at ultra-cold temperatures to remain effective—negative 70°C or colder—shipments will require dry ice containers. And while COVID-19 vaccine doses are not considered hazmat, dry ice is governed by Dangerous Goods restrictions when travelling by air.
In this podcast, Labelmaster Senior Manager Jay Johnson, an expert on cold chain packaging and logistics, shares his insights into the challenges of dry ice transport, along with the completely different challenges associated with transporting COVID-19 test samples.
Dry ice sublimates into huge volumes of carbon dioxide, which will cause sealed containers to explode and create an asphyxiation risk in closed rooms. While pharma and supply chain veterans are accustomed to mitigating these risks, COVID-19 distribution will likely involve many people who don’t have the same training or experience.
COVID-19 test samples, unlike vaccines, are classified as Dangerous Goods. They are Category B infectious substances, and they present their own packaging and logistics challenges.
Labelmaster offers a comprehensive selection of temperature controlled packaging suitable for transporting both COVID-19 vaccine doses and test samples.